Diagnostic Radiopharmaceuticals and Contrast Media Market Report

Global and Region Diagnostic Radiopharmaceuticals and Contrast Media Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：207
  • REPORT CODE：GMM916299
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Diagnostic Radiopharmaceuticals and Contrast Media market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Diagnostic Radiopharmaceuticals and Contrast Mediamarket, defines the market attractiveness level of Diagnostic Radiopharmaceuticals and Contrast Media market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Diagnostic Radiopharmaceuticals and Contrast Media industry, describes the types of Diagnostic Radiopharmaceuticals and Contrast Media market, the applications of major players and the market size, and deeply analyzes the current situation of the global Diagnostic Radiopharmaceuticals and Contrast Media market and the development prospects and opportunities of Diagnostic Radiopharmaceuticals and Contrast Media industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Diagnostic Radiopharmaceuticals and Contrast Media market in Chapter 13.

    By Player:

    • Bayer Healthcare

    • Nordion

    • Mallinckrodt

    • GE Healthcare

    • Amag Pharmaceuticals

    • Bracco Imaging

    • Medtronic

    • Guerbet

    • Daiichi Sankyo

    • Lantheus

    By Type:

    • Radiopharmaceuticals

    • Contrast Media

    By End-User:

    • Diagnostic

    • Therapeutic

    • Ionizing Radiation based Radioimaging

    • Non-Ionizing Radiation based Radioimaging

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Diagnostic Radiopharmaceuticals and Contrast Media Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Diagnostic Radiopharmaceuticals and Contrast Media Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Diagnostic Radiopharmaceuticals and Contrast Media Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Diagnostic Radiopharmaceuticals and Contrast Media Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Diagnostic Radiopharmaceuticals and Contrast Media Market Analysis and Outlook to 2022

    • 7.1 Global Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)

    • 7.2 United States Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)

    • 7.3 Europe Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)

    • 7.4 China Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)

    • 7.5 Japan Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)

    • 7.6 India Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)

    • 7.7 South Korea Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)

    8 Region and Country-wise Diagnostic Radiopharmaceuticals and Contrast Media Market Analysis and Outlook to 2028

    • 8.1 Global Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)

    • 8.2 United States Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)

    • 8.3 Europe Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)

    • 8.4 China Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)

    • 8.5 Japan Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)

    • 8.6 India Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)

    • 8.7 South Korea Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)

    9 Global Diagnostic Radiopharmaceuticals and Contrast Media Market Outlook by Types and Applications to 2022

    • 9.1 Global Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Contrast Media Consumption and Growth Rate (2017-2022)

    • 9.2 Global Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Diagnostic Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Therapeutic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Ionizing Radiation based Radioimaging Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Non-Ionizing Radiation based Radioimaging Consumption and Growth Rate (2017-2022)

    10 Global Diagnostic Radiopharmaceuticals and Contrast Media Market Outlook by Types and Applications to 2028

    • 10.1 Global Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Contrast Media Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Diagnostic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Therapeutic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Ionizing Radiation based Radioimaging Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Non-Ionizing Radiation based Radioimaging Consumption Forecast and Growth Rate (2022-2028)

    11 Global Diagnostic Radiopharmaceuticals and Contrast Media Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Diagnostic Radiopharmaceuticals and Contrast Media Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Diagnostic Radiopharmaceuticals and Contrast Media Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Diagnostic Radiopharmaceuticals and Contrast Media Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Diagnostic Radiopharmaceuticals and Contrast Media Market Competitive Analysis

    • 14.1 Bayer Healthcare

      • 14.1.1 Bayer Healthcare Company Details

      • 14.1.2 Bayer Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Bayer Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Product and Service

    • 14.2 Nordion

      • 14.2.1 Nordion Company Details

      • 14.2.2 Nordion Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Nordion Diagnostic Radiopharmaceuticals and Contrast Media Product and Service

    • 14.3 Mallinckrodt

      • 14.3.1 Mallinckrodt Company Details

      • 14.3.2 Mallinckrodt Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Mallinckrodt Diagnostic Radiopharmaceuticals and Contrast Media Product and Service

    • 14.4 GE Healthcare

      • 14.4.1 GE Healthcare Company Details

      • 14.4.2 GE Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 GE Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Product and Service

    • 14.5 Amag Pharmaceuticals

      • 14.5.1 Amag Pharmaceuticals Company Details

      • 14.5.2 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals and Contrast Media Product and Service

    • 14.6 Bracco Imaging

      • 14.6.1 Bracco Imaging Company Details

      • 14.6.2 Bracco Imaging Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Bracco Imaging Diagnostic Radiopharmaceuticals and Contrast Media Product and Service

    • 14.7 Medtronic

      • 14.7.1 Medtronic Company Details

      • 14.7.2 Medtronic Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Medtronic Diagnostic Radiopharmaceuticals and Contrast Media Product and Service

    • 14.8 Guerbet

      • 14.8.1 Guerbet Company Details

      • 14.8.2 Guerbet Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Guerbet Diagnostic Radiopharmaceuticals and Contrast Media Product and Service

    • 14.9 Daiichi Sankyo

      • 14.9.1 Daiichi Sankyo Company Details

      • 14.9.2 Daiichi Sankyo Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Daiichi Sankyo Diagnostic Radiopharmaceuticals and Contrast Media Product and Service

    • 14.10 Lantheus

      • 14.10.1 Lantheus Company Details

      • 14.10.2 Lantheus Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Lantheus Diagnostic Radiopharmaceuticals and Contrast Media Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Diagnostic Radiopharmaceuticals and Contrast Media

    • Figure Diagnostic Radiopharmaceuticals and Contrast Media Picture

    • Table Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Diagnostic Radiopharmaceuticals and Contrast Media Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Diagnostic Radiopharmaceuticals and Contrast Media Consumption by Country (2017-2022)

    • Figure United States Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)

    • Table Europe Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)

    • Figure China Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)

    • Figure Japan Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)

    • Figure India Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)

    • Figure South Korea Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast by Country (2022-2028)

    • Figure United States Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Global Contrast Media Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Global Therapeutic Consumption and Growth Rate (2017-2022)

    • Figure Global Ionizing Radiation based Radioimaging Consumption and Growth Rate (2017-2022)

    • Figure Global Non-Ionizing Radiation based Radioimaging Consumption and Growth Rate (2017-2022)

    • Figure Global Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Contrast Media Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Therapeutic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ionizing Radiation based Radioimaging Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-Ionizing Radiation based Radioimaging Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Diagnostic Radiopharmaceuticals and Contrast Media Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Diagnostic Radiopharmaceuticals and Contrast Media Export by Region (Top 5 Countries) (2017-2028)

    • Table Bayer Healthcare (Foundation Year, Company Profile and etc.)

    • Table Bayer Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Product and Service

    • Table Nordion (Foundation Year, Company Profile and etc.)

    • Table Nordion Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nordion Diagnostic Radiopharmaceuticals and Contrast Media Product and Service

    • Table Mallinckrodt (Foundation Year, Company Profile and etc.)

    • Table Mallinckrodt Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mallinckrodt Diagnostic Radiopharmaceuticals and Contrast Media Product and Service

    • Table GE Healthcare (Foundation Year, Company Profile and etc.)

    • Table GE Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)

    • Table GE Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Product and Service

    • Table Amag Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Amag Pharmaceuticals Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amag Pharmaceuticals Diagnostic Radiopharmaceuticals and Contrast Media Product and Service

    • Table Bracco Imaging (Foundation Year, Company Profile and etc.)

    • Table Bracco Imaging Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bracco Imaging Diagnostic Radiopharmaceuticals and Contrast Media Product and Service

    • Table Medtronic (Foundation Year, Company Profile and etc.)

    • Table Medtronic Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medtronic Diagnostic Radiopharmaceuticals and Contrast Media Product and Service

    • Table Guerbet (Foundation Year, Company Profile and etc.)

    • Table Guerbet Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)

    • Table Guerbet Diagnostic Radiopharmaceuticals and Contrast Media Product and Service

    • Table Daiichi Sankyo (Foundation Year, Company Profile and etc.)

    • Table Daiichi Sankyo Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi Sankyo Diagnostic Radiopharmaceuticals and Contrast Media Product and Service

    • Table Lantheus (Foundation Year, Company Profile and etc.)

    • Table Lantheus Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lantheus Diagnostic Radiopharmaceuticals and Contrast Media Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US